Speaker

Ved Srivastava

Chief Scientific Officer, Perpetual Medicines

Ved Srivastava, Chief Scientific Officer at Perpetual Medicines, is speaking at Amylin-Based Therapeutics Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “Modern Amylin Molecules: Beyond Fibrillation Toward Developable Therapeutics”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

Amylin-Based Therapeutics Summit 2026
1–3 Dec 2026Boston, United States of America
- SpeakerModern Amylin Molecules: Beyond Fibrillation Toward Developable Therapeutics

More speakers at Amylin-Based Therapeutics Summit 2026

Daniel Briere
Senior Director, Eli Lilly
Debbie Hay
Professor, Pharmacology, Otago University
Thomas Lutz
Professor, University of Zurich
Cody Moore
Director, Platform Development, iBio
Augen Pioszak
Associate Professor, Department of Biochemistry & Physiology, University of Oklahoma
Kirsten Raun
Vice President, Scientific, Novo Nordisk

See all 9 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Ved Srivastava, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].